Physician profile
Christopher Haas
NPI 1730575309
$3,288.62
in general payments reported to CMS, 2019-2025
15 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $68.09 · 2023: $2,168 · 2024: $553 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,620 · Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,620.00 |
| Food and Beverage | $1,489.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $1,620.00 | 2023 | Oes Choledochofiberscope |
| Abbvie INC. | $387.94 | 2023-2025 | |
| Boston Scientific Corporation | $387.94 | 2021-2025 | Lumenis Pulse 120h, Moses 550 D\F\L, Rezum Generator |
| Endo Pharmaceuticals INC. | $234.57 | 2022-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $125.34 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $117.79 | 2025 | |
| Janssen Biotech, INC. | $70.47 | 2024 | Erleada, Akeega |
| Astellas Pharma US INC | $67.36 | 2023-2024 | Xtandi, Myrbetriq |
| 180 Medical, INC. | $57.75 | 2024-2025 | Speedicath, Gentlecath |
| Merck Sharp & Dohme LLC | $53.09 | 2024 | Keytruda |
| C. R. Bard, INC. & Subsidiaries | $45.52 | 2024 | Bard Urinary Drainage Bag |
| Axonics, INC. | $40.34 | 2023 | Axonics |
| Coloplast Corp | $35.47 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $23.45 | 2025 | Adstiladrin |
| Telix Pharmaceuticals | $21.59 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.